Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A 40-week Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSD (P306)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03508700
Recruitment Status : Completed
First Posted : April 26, 2018
Last Update Posted : October 1, 2019
Information provided by (Responsible Party):
Tonix Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 30, 2019
Actual Study Completion Date : September 30, 2019